Laponis Adam 4
4 · Twist Bioscience Corp · Filed Nov 6, 2024
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Award
Common Stock
2024-11-04+20,000→ 93,397 total
Footnotes (1)
- [F1]Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.